Docusign Inc. (NASDAQ:DOCU – Get Free Report) CFO Blake Jeffrey Grayson sold 15,000 shares of Docusign stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $60.00, for a total value of $900,000.00. Following the sale, the chief financial officer directly owned 126,429 shares in the company, valued at $7,585,740. The trade was a 10.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Blake Jeffrey Grayson also recently made the following trade(s):
- On Wednesday, July 1st, Blake Jeffrey Grayson sold 15,000 shares of Docusign stock. The stock was sold at an average price of $45.55, for a total value of $683,250.00.
Docusign Price Performance
Docusign stock opened at $58.10 on Thursday. The business has a 50 day moving average of $49.43 and a 200-day moving average of $48.28. The company has a market capitalization of $11.09 billion, a P/E ratio of 37.73, a P/E/G ratio of 1.75 and a beta of 0.87. Docusign Inc. has a 1 year low of $40.16 and a 1 year high of $86.65.
Wall Street Analyst Weigh In
Several research analysts have commented on the company. Citigroup lifted their target price on Docusign from $50.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, June 5th. Wedbush cut their price objective on Docusign from $60.00 to $58.00 and set a “neutral” rating on the stock in a research note on Friday, June 5th. Needham & Company LLC reiterated a “hold” rating on shares of Docusign in a report on Friday, June 5th. Wall Street Zen lowered shares of Docusign from a “strong-buy” rating to a “buy” rating in a report on Sunday, August 2nd. Finally, Wells Fargo & Company dropped their price target on shares of Docusign from $60.00 to $55.00 and set an “equal weight” rating on the stock in a research report on Friday, June 5th. Three equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $60.27.
View Our Latest Analysis on Docusign
Institutional Investors Weigh In On Docusign
Several large investors have recently added to or reduced their stakes in the business. Modus Advisors LLC bought a new position in shares of Docusign during the 4th quarter worth approximately $27,000. Torren Management LLC acquired a new stake in shares of Docusign during the 4th quarter worth approximately $28,000. Cary Street Partners Investment Advisory LLC increased its stake in shares of Docusign by 309.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 561 shares of the company’s stock valued at $38,000 after acquiring an additional 424 shares in the last quarter. Basepoint Wealth LLC bought a new stake in shares of Docusign in the 4th quarter valued at $39,000. Finally, WealthCollab LLC lifted its position in shares of Docusign by 372.4% during the 1st quarter. WealthCollab LLC now owns 855 shares of the company’s stock valued at $41,000 after acquiring an additional 674 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Read More
- Five stocks we like better than Docusign
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
